Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    CHIESI USA INC

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 4CHIESI

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass

    01

    CHIESI

    NICARDIPINE HYDROCHLORIDE

    arrow
    Antibody Engineering
    Not Confirmed

    CHIESI

    U.S.A
    arrow
    Antibody Engineering
    Not Confirmed

    Patent Expiration Date : 2027-04-18

    NICARDIPINE HYDROCHLORIDE

    US Patent Number : 7659291

    Drug Substance Claim :

    Drug Product Claim :

    Application Number : 19734

    Patent Use Code : U-1029

    Delist Requested :

    Patent Use Description : METHOD FOR TREATING AC...

    Patent Expiration Date : 2027-04-18

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    CHIESI

    NICARDIPINE HYDROCHLORIDE

    arrow
    Antibody Engineering
    Not Confirmed

    CHIESI

    U.S.A
    arrow
    Antibody Engineering
    Not Confirmed

    Patent Expiration Date : 2027-04-18

    NICARDIPINE HYDROCHLORIDE

    US Patent Number : 7659291

    Drug Substance Claim :

    Drug Product Claim :

    Application Number : 19734

    Patent Use Code : U-1029

    Delist Requested :

    Patent Use Description : METHOD FOR TREATING AC...

    Patent Expiration Date : 2027-04-18

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    CHIESI

    NICARDIPINE HYDROCHLORIDE

    arrow
    Antibody Engineering
    Not Confirmed

    CHIESI

    U.S.A
    arrow
    Antibody Engineering
    Not Confirmed

    Patent Expiration Date : 2027-04-18

    NICARDIPINE HYDROCHLORIDE

    US Patent Number : 7659291

    Drug Substance Claim :

    Drug Product Claim :

    Application Number : 19734

    Patent Use Code : U-1029

    Delist Requested :

    Patent Use Description : METHOD FOR TREATING AC...

    Patent Expiration Date : 2027-04-18

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    CHIESI

    NICARDIPINE HYDROCHLORIDE

    arrow
    Antibody Engineering
    Not Confirmed

    CHIESI

    U.S.A
    arrow
    Antibody Engineering
    Not Confirmed

    Patent Expiration Date : 2027-04-18

    NICARDIPINE HYDROCHLORIDE

    US Patent Number : 7659291

    Drug Substance Claim :

    Drug Product Claim :

    Application Number : 19734

    Patent Use Code : U-1029

    Delist Requested :

    Patent Use Description : METHOD FOR TREATING AC...

    Patent Expiration Date : 2027-04-18

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF